Gastrointestinal Cancer

Top Story

FDA grants priority review to Opdivo for advanced liver cancer

May 24, 2017

The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer.

The designation applies to use of nivolumab (Opdivo, Bristol-Myers Squibb), a PD-1 immune checkpoint inhibitor, in patients previously treated with sorafenib (Nexavar, Bayer).

In the Journals

HCC in presence of HCV decreases cure rate in DAA treatment

May 24, 2017
Patients with hepatocellular carcinoma and hepatitis C were less likely to achieve sustained virologic response while receiving direct-acting antiviral therapy compared…

Nektar, Takeda enter collaboration to investigate NKTR-214 combinations

May 24, 2017
Nektar Therapeutics and Takeda entered into a research collaboration to evaluate the combination of NKTR-214 and several other compounds in tumor models of lymphoma…
In the Journals

Early-onset HCC linked to HBV in South American patients

May 24, 2017
Hepatocellular carcinoma was linked to patients with hepatitis B in South America, particularly those younger than 50 years, according to results of a retrospective…
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News Coverage

VIDEO: Studies address how to better use genetic testing

June 15, 2016
More »
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
FDA News

FDA grants priority review to Opdivo for advanced liver cancer

May 24, 2017
The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer. The…

In the Journals

HCC in presence of HCV decreases cure rate in DAA treatment

May 24, 2017
Patients with hepatocellular carcinoma and hepatitis C were less likely to achieve sustained virologic response while receiving direct-acting…

Nektar, Takeda enter collaboration to investigate NKTR-214 combinations

May 24, 2017
Nektar Therapeutics and Takeda entered into a research collaboration to evaluate the combination of NKTR-214 and several other compounds in tumor…

In the Journals

Early-onset HCC linked to HBV in South American patients

May 24, 2017
Hepatocellular carcinoma was linked to patients with hepatitis B in South America, particularly those younger than 50 years, according to results of…

FDA News

FDA grants priority review to Keytruda for advanced gastric, gastroesophageal junction adenocarcinoma

May 24, 2017
The FDA granted priority review to pembrolizumab for the treatment of recurrent or advanced gastric or gastroesophageal junction adenocarcinoma…

Imaging Analysis

Liver metastasis from known malignant mixed Müllerian tumor

HemOnc Today, May 25, 2017
Ana M. Franceschi, MD; Munir Ghesani, MD, FACNM
A 59-year-old woman presented to her primary care physician with heavy vaginal bleeding and urinary retention. She underwent a total abdominal…

FDA News

FDA grants accelerated approval to Keytruda for solid tumors with specific biomarker

May 23, 2017
The FDA today granted accelerated approval to pembrolizumab for adults and children with unresectable or metastatic, microsatellite…

In the Journals

Elderly black patients more likely to develop colorectal cancer

May 22, 2017
The risk for interval colorectal cancer was 31% greater in elderly black patients enrolled in Medicare than in white patients, with a more noticeable…

In the Journals Plus

Travel to academic centers improves pancreatic cancer survival

May 22, 2017
Patients with pancreatic ductal adenocarcinoma who traveled from urban or rural counties to receive surgical care at academic centers demonstrated…

Meeting News

Normal weight in childhood lowers males' risk for adult colon cancer

May 22, 2017
Overweight boys are at increased risk for adult colon cancer compared with normal-weight boys; however, achieving a healthy weight by young adulthood…

More Headlines »
Advertisement
Advertisement